More importantly, in vivo xenograft tumorigenicity, tumor invasion, and metastasis assays confirmed that Oct4/Nanog contributed to HCC intrahepatic dissemination and lung metastasis. The gene discussed is NANOG; the disease is hepatocellular carcinoma.